DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8+ T cell responses

Purpose T cell-mediated immune responses, and particularly activation of polyfunctional T cells that simultaneously produce multiple cytokines, are necessary for the control of Mycobacterium tuberculosis. In the present study, we examined if DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B (RpfB) elicits polyfunctional T cell responses in mice. Materials and Methods C57BL/6 mice were immunized intramuscularly three times, at 3-week intervals, with RpfB-expressing plasmid DNA. For comparison, protein immunization was performed with recombinant RpfB in control mice. After immunization, RpfB-specific T cell responses were assessed by interferon-γ (IFN-γ) enzyme-linked immunosorbent spot assay and intracellular cytokine staining (ICS), and T cell polyfunctionality was assessed from the ICS data. Results RpfB DNA immunization induced not only humoral immune responses, but also CD8+ and CD4+ T cell responses. Immunodominant T-cell epitopes were identified within RpfB by assays with overlapping peptides. RpfB DNA immunization elicited a polyfunctional CD8+ T cell response that was dominated by a functional phenotype of IFN-γ+/TNF-α+/IL-2-/CD107a+. Conclusion RpfB DNA immunization elicits polyfunctional CD8+ T cell responses, suggesting that RpfB DNA immunization might induce protective immunity against tuberculosis.

[1]  J. Hamid,et al.  A Human Type 5 Adenovirus–Based Tuberculosis Vaccine Induces Robust T Cell Responses in Humans Despite Preexisting Anti-Adenovirus Immunity , 2013, Science Translational Medicine.

[2]  R. Falk Overcoming the Global Crisis , 2013 .

[3]  E. Shin,et al.  Two Distinct Functional Patterns of Hepatitis C Virus (HCV)-Specific T Cell Responses in Seronegative, Aviremic Patients , 2013, PloS one.

[4]  A. Folgori,et al.  Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus. , 2012, Gastroenterology.

[5]  Elena Losina,et al.  Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  W. Kang,et al.  Adjuvant effect of bacterial outer membrane vesicles with penta-acylated lipopolysaccharide on antigen-specific T cell priming. , 2011, Vaccine.

[7]  S. Morris,et al.  Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. , 2011, Vaccine.

[8]  M. Tameris,et al.  The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults. , 2010, American journal of respiratory and critical care medicine.

[9]  M. Tameris,et al.  Modified vaccinia Ankara‐expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells , 2009, European journal of immunology.

[10]  D. Dearnaley,et al.  DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. , 2009, Human gene therapy.

[11]  Tom H M Ottenhoff,et al.  Overcoming the global crisis: “Yes, we can”, but also for TB … ? , 2009, European journal of immunology.

[12]  T. Ottenhoff,et al.  Analysis of Mycobacterium tuberculosis-Specific CD8 T-Cells in Patients with Active Tuberculosis and in Individuals with Latent Infection , 2009, PloS one.

[13]  A. Hill,et al.  Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice , 2008, The Journal of Immunology.

[14]  D. Weiner,et al.  Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques. , 2008, Vaccine.

[15]  G. Kaplan,et al.  The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro , 2007, Molecular microbiology.

[16]  Mario Roederer,et al.  Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major , 2007, Nature Medicine.

[17]  Mario Roederer,et al.  Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses , 2007, The Journal of experimental medicine.

[18]  D. Montefiori,et al.  Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques , 2007, Journal of Virology.

[19]  F. Dieli,et al.  Phenotypical and Functional Analysis of Memory and Effector Human CD8 T Cells Specific for Mycobacterial Antigens1 , 2006, The Journal of Immunology.

[20]  Mario Roederer,et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.

[21]  W. Jacobs,et al.  Deletion of the Mycobacterium tuberculosis Resuscitation-Promoting Factor Rv1009 Gene Results in Delayed Reactivation from Chronic Tuberculosis , 2006, Infection and Immunity.

[22]  C. Dye,et al.  Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.

[23]  Michael Young,et al.  Mutants of Mycobacterium tuberculosis Lacking Three of the Five rpf-Like Genes Are Defective for Growth In Vivo and for Resuscitation In Vitro , 2005, Infection and Immunity.

[24]  Wenming Zhu,et al.  Resuscitation factors from mycobacteria: homologs of Micrococcus luteus proteins. , 2003, Tuberculosis.

[25]  A. Kaprelyants,et al.  Proteins of the Rpf Family: Immune Cell Reactivity and Vaccination Efficacy against Tuberculosis in Mice , 2003, Infection and Immunity.

[26]  J. Flynn,et al.  CD8+ T cells in tuberculosis. , 2002, American journal of respiratory and critical care medicine.

[27]  S. Behar,et al.  Gamma Interferon-Producing CD4+ T Lymphocytes in the Lung Correlate with Resistance to Infection withMycobacterium tuberculosis , 2001, Infection and Immunity.

[28]  G. Schoolnik,et al.  Comparative genomics of BCG vaccines by whole-genome DNA microarray. , 1999, Science.

[29]  D B Kell,et al.  A bacterial cytokine. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. E. M. Fine,et al.  Variation in protection by BCG: implications of and for heterologous immunity , 1995, The Lancet.

[31]  C S Berkey,et al.  The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. , 1995, Pediatrics.

[32]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[33]  C S Berkey,et al.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.

[34]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[35]  J. Flynn,et al.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.

[36]  Graham,et al.  T-cell-mediated protection of mice against virulent Mycobacterium tuberculosis , 1989, Infection and immunity.

[37]  S. Kaufmann,et al.  Impaired resistance to Mycobacterium tuberculosis infection after selective in vivo depletion of L3T4+ and Lyt-2+ T cells , 1987, Infection and immunity.

[38]  T. Ottenhoff,et al.  Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines. , 2012, Microbes and infection.

[39]  S. Kaufmann,et al.  Apoptotic vesicles crossprime CD8 T cells and protect against tuberculosis. , 2006, Immunity.

[40]  S. Behar,et al.  Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity. , 2006, Critical reviews in immunology.

[41]  G. Colditz,et al.  Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[42]  P. Lagrange [Preventive vaccination against tuberculosis: BCG]. , 1984, Annales de pediatrie.